‘Morbius’ Shows Limits of Comic Book Love With $39 Million Debut
(Bloomberg) -- Sony Group's hot run of comic-book films showed its limits after “Morbius,” a dark movie with a blood-sucking antihero, delivered less than half of the opening weekend ticket sales of last year's “Venom: Let There Be Carnage.”
The movie, which tells the origin story of villain Doctor Michael Morbius, generated $39.1 million in U.S. and Canadian ticket sales, Sony said in an email Sunday. That was below the $40.2 million that researcher BoxOffice.com had forecast. Sony projected $33 million going into the weekend before upping its forecast to as much as $41.5 million on Saturday.
“Morbius” trailed the opening weekend of Warner Bros. gritty “The Batman,” which took in $128.5 million in its domestic debut last month, as well that of Sony's “Venom” sequel, which brought in $90.1 million last year. Sony's “Spider-Man: No Way Home” grossed a pandemic-era record of $260 million in its December opening weekend.
Key Insights
- Just 17% of critics recommended “Morbius” according to review aggregator site RottenTomatoes.com, with one critic calling it a “huge letdown.” Audiences were more generous, giving it a score of about 69%. The film, which saw its original summer 2020 release date delayed several times due to the pandemic, was only available in theaters.
- Sony developed “Morbius” in collaboration with Walt Disney Co.'s Marvel unit. Oscar-winner Jared Leto stars in the first time the character has appeared in a film. “Morbius” had a modest -- by superhero film standards -- budget of $75 million.
- Superhero films have been the one dependable draw during the pandemic, attracting an audience of older children and young adults that were more comfortable than others returning to cinemas.
- Future April debuts include “Sonic the Hedgehog 2” from Paramount and “Fantastic Beasts: The Secrets of Dumbledore” from AT&T Inc.'s Warner Bros., as the industry continues its return to theaters and tests filmgoers' appetites for doing the same.
©2022 Bloomberg L.P.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
